Motor function impairment during long-term antipsychotic treatment of patients with schizophrenia: 3 year results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study

被引：0
作者：
McBride, M.
Dossenbach, M.
Suh, S. Y.
Lee, P.
Tamayo, J.
West, T.
Herrera, M.
Ruiz, I.
Suarn, S.
机构：
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：445 / 446
页数：2
相关论文
共 50 条
  • [21] Change in clinical status and side effects of patients treated with either olanzapine or risperidone: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
    O'Halloran, RA
    Boland, J
    Lee, PG
    Dossenbach, M
    Kim, CE
    Jon, DI
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 : A11 - A11
  • [22] Change in clinical status and side effects of patients treated with either olanzapine or risperidone: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (ic-soho) observational study
    Osnayo, JL
    Ibarra, RR
    O'Halloran, RA
    Boland, JM
    Brunner, E
    Levitt, L
    Dossenbach, M
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 28S - 29S
  • [23] Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol:: 12-Month follow-up of the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
    Dossenbach, M
    Arango-Dávila, C
    Ibarra, HS
    Landa, E
    Aguilar, J
    Caro, O
    Leadbetter, J
    Assunçao, S
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 1021 - 1030
  • [24] The Schizophrenia Outpatient Health Outcomes (SOHO) study:: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
    Ciudad, Antonio
    Haro, Josep Maria
    Alonso, Jordi
    Bousono, Manuel
    Suarez, David
    Novick, Diego
    Gilaberte, Inmaculada
    EUROPEAN PSYCHIATRY, 2008, 23 (01) : 1 - 7
  • [25] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
    Novick, D
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
  • [26] Change in clinical status and side effects of patients treated with either olanzapine or risperidone:: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
    Gargoloff, PR
    O'Halloran, RA
    Boland, JM
    Brunner, E
    Dossenbach, M
    Levitt, L
    Valencia, A
    Landa, E
    González, C
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 283 - 284
  • [27] Predictors of treatment outcomes in previously untreated patients with schizophrenia: Results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Gasquet, I
    Novick, D
    Lorenzo, M
    Tzivelekis, S
    Ratcliffe, M
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 197 - 197
  • [28] Predictors of treatment outcomes in previously untreated patients with schizophrenia: Results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Gasquet, I
    Novick, D
    Lorenzo, M
    Tzivelekis, S
    Ratcliffe, M
    Alonso, J
    Gasquet, I
    Kristensen, H
    Jones, PB
    Knapp, M
    Lepine, JP
    Mavreas, V
    Murray, D
    Naber, D
    Pancheri, P
    Slooff, CJ
    Teixeira, JM
    EUROPEAN PSYCHIATRY, 2004, 19 : 172S - 172S
  • [29] Tolerability of outpatient antipsychotic treatment:: 36-Month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, D.
    Haro, J. M.
    Suarez, D.
    Bushe, C.
    Lepine, J. P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S161 - S161
  • [30] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
12345